E

Exact Therapeutics AS
OSE:EXTX

Watchlist Manager
Exact Therapeutics AS
OSE:EXTX
Watchlist
Price: 1.36 NOK -13.92% Market Closed
Market Cap: 86m NOK

Net Margin
Exact Therapeutics AS

0%
Current
0%
Average
-6.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-72.2m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Exact Therapeutics AS
Glance View

Market Cap
86m NOK
Industry
Biotechnology

EXACT Therapeutics AS is a clinical stage biopharmaceutical company, which engages in the research and development of novel platform for ultrasound mediated therapeutic amplification. The company is headquartered in Oslo, Oslo and currently employs 8 full-time employees. The company went IPO on 2020-07-14. ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The firm's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. The company is done through harnessing the power of ultrasound in combination with ACT formulation.

EXTX Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-72.2m
/
Revenue
0
What is the Net Margin of Exact Therapeutics AS?

Based on Exact Therapeutics AS's most recent financial statements, the company has Net Margin of 0%.

Back to Top